From Forbes November 04, 2016 Professor Tomas Philipson Harris Public Policy Professor Tomas PhilipsonHarris Public Policy Professor Tomas Philipson discusses the current approval process for drugs and its ability to make all-or-nothing decisions based on limited evidence. Full coverage is available at Forbes. Upcoming Events More events Ask Admissions: SDG (Sustainable Development Goals) Challenge Program for High School Students Mon., April 22, 2024 | 8:00 AM Ask Admissions: Credential Programs Mon., April 22, 2024 | 9:00 PM Ask Admissions: Credential Programs Tue., April 23, 2024 | 7:00 AM
April 08, 2024 How Medicare beneficiaries with Part D plans can help ensure their medications are covered